Loading...
Loading...
India's enalapril imports from CANADA total $492 across 13 shipments from 4 foreign suppliers. TEVA CANADA LIMITED leads with $185 in import value; the top 5 suppliers together control 100.0% of this origin. Leading Indian buyers include APOTEX RESEARCH PRIVATE LIMITED. This corridor reflects India's pharmaceutical import demand for enalapril — a diversified sourcing base with multiple active suppliers from CANADA.

TEVA CANADA LIMITED is the leading Enalapril supplier from CANADA to India, with import value of $185 across 2 shipments. The top 5 suppliers — TEVA CANADA LIMITED, Apotex Inc., APOTEX INC, APOTEX INC, — collectively account for 100.0% of total import value from this origin.
Ranked by import value (USD) · Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | TEVA CANADA LIMITED | $185 | 2 | 37.6% |
| 2 | Apotex Inc. | $155 | 2 | 31.5% |
| 3 | APOTEX INC | $101 | 6 | 20.5% |
| 4 | APOTEX INC, | $51 | 3 | 10.5% |
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | APOTEX RESEARCH PRIVATE LIMITED | $307 | 11 | 62.4% |
| 2 | ACTAVIS PHARMA DEVELOPMENT CENTRE PRIVATE LIMITED | $185 | 2 | 37.6% |
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
The top Enalapril suppliers from CANADA to India include TEVA CANADA LIMITED, Apotex Inc., APOTEX INC. The leading supplier is TEVA CANADA LIMITED with import value of $185 USD across 2 shipments. India imported Enalapril worth $492 USD from CANADA in total across 13 shipments.
India imported Enalapril worth $492 USD from CANADA across 13 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
The main Indian buyers of Enalapril sourced from CANADA include APOTEX RESEARCH PRIVATE LIMITED, ACTAVIS PHARMA DEVELOPMENT CENTRE PRIVATE LIMITED. The largest buyer is APOTEX RESEARCH PRIVATE LIMITED with $307 in imports across 11 shipments.
The total value of Enalapril imports from CANADA to India is $492 USD, across 13 shipments and 4 foreign suppliers. Data source: Indian Customs (DGFT).
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
13 Verified Shipments
4 suppliers, 2 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists